Evidence map›Paper›PMID 24550112›Full record

ArticleDevelopment (Cambridge, England)2014

Sall1 balances self-renewal and differentiation of renal progenitor cells.

Jeannine M Basta, Lynn Robbins, Susan M Kiefer, Dale Dorsett, Michael Rauchman

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Circulation. Genomic and precision medicine · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Histone deacetylases and their inhibitors in kidney diseases.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Principles of human and mouse nephron development.Nature reviews. Nephrology · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jeannine M BastaDepartment of Internal Medicine, Saint Louis University, St Louis, MO 63104, USA.
Lynn Robbins
Susan M Kiefer
Dale Dorsett
Michael Rauchman

Funding

Sall1 in Kidney Development and Townes-Brocks SyndromeR01DK067222 · NIDDK · SAINT LOUIS UNIVERSITY · PI RAUCHMAN, MICHAEL I · 2004 to 2010
$1.4M
NIDDK NIH HHS R01 DK067222
6 · The paper itself

Abstract

The formation of the proper number of functional nephrons requires a delicate balance between renal progenitor cell self-renewal and differentiation. The molecular factors that regulate the dramatic expansion of the progenitor cell pool and differentiation of these cells into nephron precursor structures (renal vesicles) are not well understood. Here we show that Sall1, a nuclear transcription factor, is required to maintain the stemness of nephron progenitor cells. Transcriptional profiling of Sall1 mutant cells revealed a striking pattern, marked by the reduction of progenitor genes and amplified expression of renal vesicle differentiation genes. These global changes in gene expression were accompanied by ectopic differentiation at E12.5 and depletion of Six2+Cited1+ cap mesenchyme progenitor cells. These findings highlight a novel role for Sall1 in maintaining the stemness of the progenitor cell pool by restraining their differentiation into renal vesicles.

Indexed as

AnimalsCell CycleCell DifferentiationFemaleImmunohistochemistryIn Situ HybridizationKidneyMiceReal-Time Polymerase Chain ReactionStem CellsTranscription FactorsSall1 protein, mouseTranscription FactorsCap mesenchymeEmbryonic kidney developmentNephron differentiationRenal progenitor cellRenal vesicleSall1

Identifiers

PMID24550112
PMCPMC3929412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.